Ana Monteiro Ferreira

Ana Monteiro Ferreira

Auto-generated profile, based on publicly available information

Ana Monteiro Ferreira

Department of Genetics, University Medical Center Groningen, University of Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in European Journal of Cancer
Verified
Journal Article
Closed access
Sérgia VelhoSérgia Velho
Sérgia Velho
COCarla Oliveira
Carla Oliveira
AFAna Ferreira
Ana Ferreira
AFAntónio Carlos Ferreira
António Carlos Ferreira
GSGianpaolo Suriano
Gianpaolo Suriano
Raquel SerucaRaquel Seruca
Raquel Seruca

4 September 2006 in Oncogene
Verified
Journal Article
Open access
PDF file
COCarla Oliveira
Carla Oliveira
Sérgia VelhoSérgia Velho
Sérgia Velho
CMC Moutinho
C Moutinho
AFA Ferreira
A Ferreira
Ana PretoAna Preto
Ana Preto
Raquel SerucaRaquel Seruca
Raquel Seruca
In sporadic colorectal cancer (CRC), KRAS are alternative to BRAF mutations and occur, respectively, in 30 and 10% of cases. Few reports addressed the association between KRAS–BRAF mutations and tumour progression specifically in sporadic microsatellite-stable (MSS) CRC. We screened KRAS and BRAF in 250 MSS primary CRC and 45 lymph node (LN) metastases and analysed the pathological features of the cases to understand the involvement of KRAS–BRAF activation in progression and metastasis. Forty-five per cent of primary MSS CRCs carried mutations in at least one of these genes and mutations were associated with wall invasion (P=0.02), presence and number of LN metastases (P=0.02 and P=0.03, respectively), distant metastases (P=0.004) and advanced stage (P=0.01). We demonstrated that KRAS and BRAF are alternative events in Tis and T1 MSS CRC and, KRAS rather than BRAF mutations, contributed to the progression of MSS CRC. The frequency of KRAS and/or BRAF mutations was higher in LN metastases than in primary carcinomas (P=0.0002). Mutated LN metastases displayed KRAS associated or not with BRAF mutations. BRAF mutations were never present as a single event. Concomitant KRAS and BRAF mutations increased along progression of MSS CRCs, suggesting that activation of both genes is likely to harbour a synergistic effect.

4 May 2011 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
PAPia Alhopuro
Pia Alhopuro
HSHeli Sammalkorpi
Heli Sammalkorpi
INIina Niittymäki
Iina Niittymäki
MBMia Biström
Mia Biström
ARAnniina Raitila
Anniina Raitila
LALauri A. Aaltonen
Lauri A. Aaltonen
Defects in the mismatch repair system lead to microsatellite instability (MSI), a feature observed in ∼ 15% of all colorectal cancers (CRCs). Microsatellite mutations that drive tumourigenesis, typically inactivation of tumour suppressors, are selected for and are frequently detected in MSI cancers. Here, we evaluated somatic mutations in microsatellite repeats of 790 genes chosen based on reduced expression in MSI CRC and existence of a coding mononucleotide repeat of 6–10 bp in length. All the repeats were initially sequenced in 30 primary MSI CRC samples and whenever frameshift mutations were identified in >20%, additional 70 samples were sequenced. To distinguish driver mutations from passengers, we similarly analyzed the occurrence of frameshift mutations in 121 intronic control repeats and utilized a statistical regression model to determine cut‐off mutation frequencies for repeats of all types (A/T and C/G, 6–10 bp). Along with several know target genes, including TGFBR2, ACVR2, and MSH3, six novel candidate driver genes emerged that harbored significantly more mutations than identical control repeats. The mutation frequencies in 100 MSI CRC samples were 51% in G8 of GLYR1, 47% in T9 of ABCC5, 43% in G8 of WDTC1, 33% in A8 of ROCK1, 30% in T8 of OR51E2, and 28% in A8 of TCEB3. Immunohistochemical staining of GLYR1 revealed defective protein expression in tumors carrying biallelic mutations, supporting a loss of function hypothesis. This is a large scale, unbiased effort to identify genes that when mutated are likely to contribute to MSI CRC development.

1 August 2004 in European Journal of Cancer
Verified
Journal Article
Closed access
COCarla Oliveira
Carla Oliveira
PFPaulo Ferreira
Paulo Ferreira
SNSérgio Nabais
Sérgio Nabais
LCLuisa Campos
Luisa Campos
AFAna Ferreira
Ana Ferreira
Raquel SerucaRaquel Seruca
Raquel Seruca

25 March 2011 in Molecules
Verified
Journal Article
Open access
PDF file
Elsa LamyElsa Lamy
Elsa Lamy
Harshadrai RawelHarshadrai Rawel
Harshadrai Rawel
FSFlorian J. Schweigert
Florian J. Schweigert
Fernando Capela e SilvaFernando Capela e Silva
Fernando Capela e Silva
AFAna Ferreira
Ana Ferreira
ESElvira Sales-Baptista
Elvira Sales-Baptista
Sheep, cattle and goat are domestic ruminants of significant economic interest in the Mediterranean region. Although sharing the same pasture ranges, they ingest different plants and plant parts and, consequently different levels of tannins. This suggests an ability to detect and adapt ingestion according to animal physiological limits of tolerance for plant secondary metabolites. This review will detail the effects of dietary tannins on feeding behavior, and the role of the oral cavity in this process, with focus on such ruminant species. The role of salivary protein profile in tannin perception in the oral cavity, and as a defense mechanism, will be discussed.

5 September 2014 in Human Mutation
Verified
Journal Article
Closed access
PDF file
AFAna M. Ferreira
Ana M. Ferreira
ITIina Tuominen
Iina Tuominen
KDKrista van Dijk-Bos
Krista van Dijk-Bos
BSBahram Sanjabi
Bahram Sanjabi
TSTineke van der Sluis
Tineke van der Sluis
RHRobert M.W. Hofstra
Robert M.W. Hofstra
Ribosomal Protein L22 (RPL22) encodes a protein that is a component of the 60S subunit of the ribosome. Variants in this gene have recently been linked to cancer development. Mutations in an A8 repeat in exon 2 were found in a recent study in 52% of microsatellite-unstable endometrial tumors. These tumors are particularly prone to mutations in repeats due to mismatch repair deficiency. We screened this coding repeat in our collection of microsatellite-unstable endometrial tumors (EC) and colorectal tumors (CRC). We found 50% mutation frequency for EC and 77% mutation frequency for CRC. These results confirm the previous study on the involvement of RPL22 in EC and, more importantly, reports for the first time such high mutation frequency in this gene in colorectal cancer. Furthermore, considering the high mutation frequency found, our data point toward an important role for RPL22 in microsatellite instability carcinogenesis.